As the world watches a concerning new strain of SARS-COV-2 first identified in the United Kingdom, one global biote...
Huami Corp. on Jan 5, 2020 announced that it has entered into an agreement to acquired 29.99% of the outstanding shares ...
The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...
INOVIO, a US based biotechnology company focused on bringing to market precisely designed DNA medicines to treat and pro...
ImmVira Group Company, a biotechnology platform dedicated to the development of oncolytic virus(OV) and vector type appr...
CIMC Enric Holdings has announced that its subsidiary Zhangjiagang CIMC Sanctum Cryogenic Equipment Co., Ltd recent...
OUE Lippo Healthcare, based in Singapore, has announced that following the formation of the Joint Venture for ...
DXY, a leading digital healthcare technology company in China, announced the completion of a $500 million fina...
Urban China is expected to have the highest number of diagnosed incident cases of non-small cell lung cancer (NSCLC) amo...
BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...
NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...
As the new coronavirus began to spread globally, Suntrap Life Technologies Ltd established a special research team. The ...
WuXi Biologics, a global company with leading open-access biologics technology platforms, and Bayer, have announced an a...
On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Env...
The Chinese University of Hong Kong (CUHK) has recently developed a fully automated, low cost and rapid microrobotic dia...
China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...
Takeda Pharmaceutical Company, headquartered in Japan, has announced that it has entered into an agreement to divest a p...
BioNTech and Shanghai Fosun Pharmaceutical (Group) Co, Ltd have announced an agreement to supply Mainland China with 100...
